Sorry, no jobs matched your search criteria.
However, here are some other roles you might find interesting.
This role involves leading the development and delivery of strategic life sciences partnerships for the South West Secure Data Environment (SWSDE). Responsibilities include building relationships with life science organizations, developing commercial models, and ensuring governance and ethical standards are maintained.
This role involves leading patient engagement initiatives in clinical research, ensuring patient perspectives shape clinical trial design and participant experiences. Responsibilities include advising study teams, building relationships with patient advocacy groups, and representing CSL externally to promote patient-centric research.
This role involves leading patient engagement initiatives in clinical research, ensuring patient perspectives shape clinical trial design, and building relationships with patient advocacy groups and healthcare institutions. The position requires significant experience in clinical research and patient engagement, with a focus on protocol development and site management.
Leads strategic sourcing and evaluation of early-stage (preclinical to Phase 1) external innovation opportunities in the Cardiovascular/Renal therapeutic area. Drives due diligence, shapes partnering strategies, and collaborates with Business Development to execute transactions. Embedded in the Therapeutic Area Leadership Team to align external innovation with portfolio planning.
This role leads the identification, evaluation, and advancement of early-stage external innovation opportunities in the Cardiovascular/Renal therapeutic area. The individual will shape sourcing strategies, co-lead cross-functional assessment of new product opportunities, and drive due diligence and transaction execution in collaboration with Business Development. Embedded in the Therapeutic Area Leadership Team, the position plays a strategic role in portfolio development and external engagement with biotech, academia, and investors.
